Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,468,480
-$697,450 QoQ
Shares Held
530,856
-9.8% QoQ
Ownership
0.662%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 124 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. AVIR ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in AVIR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,468,480 | 530,856 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,165,930 | 588,463 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $986,405 | 340,140 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,078,764 | 299,657 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $773,237 | 258,608 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,045,651 | 312,135 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,008,108 | 300,928 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $732,641 | 221,342 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $836,557 | 207,069 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $697,961 | 228,840 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $783,069 | 261,023 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,143,396 | 305,721 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $938,200 | 280,060 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,169,872 | 243,217 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,367,784 | 240,384 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,613,261 | 227,220 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,456,222 | 201,693 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,499,337 | 279,568 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $25,005,668 | 713,225 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $8,167,210 | 380,224 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $15,696,109 | 254,188 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,179,320 | 243,641 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||